Ananda Devices Inc.
$699,000.00 CAD
≈ 9 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2022-2023
- Agreement period
- September 26, 2022 – March 14, 2024
- Reference
- nrc-cnrc:172-2022-2023-Q3-997002
Published purpose
Neuromuscular diseases (NMDs) affect approximately 13 million worldwide, there is no cure and no effective therapy. There is a major need for robust, scalable, and reproducible in vitro models of human neuromuscular junctions (NMJ) to test therapeutic candidates. Ananda Devices, guided by the needs from the top pharmaceutical company in this market, developed a first-in-class, patent protected technology that enables the establishment of a highly standardized human NMJ in vitro. In this project, we scale up this platform with high reproducibility and quality.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions